Breast Cancer Clinical Trials in Pittsburgh

Showing 281-300 of 363 trials

Letrozole in Treating Postmenopausal Women With Stage I, II or III Breast Cancer That Can Be Removed by Surgery

NCT00651976

RATIONALE: Hormone therapy using letrozole may fight breast cancer by lowering the amount of estrogen the body makes. Giving letrozole before surgery allows us to monitor the effects of letrozole on the tumor on a molecular level and determine markers of response to treatment. PURPOSE: This study will show us how well letrozole works in treating postmenopausal women with stage I, II or III breast cancer that can be removed by surgery.

Breast Cancer

Vanderbilt-Ingram Cancer Center213 participantsStarted Mar 2008

Atlanta, Georgia, United States • Tulsa, Oklahoma, United States • Pittsburgh, Pennsylvania, United States +2 more locations

COMPLETED< 1 mile

Measuring the Impact of MammaPrint on Adjuvant and Neoadjuvant Treatment in Breast Cancer Patients: A Prospective Registry

NCT02670577

The scope of this study is to measure the impact of MammaPrint on treatment in Hormone Receptor (HR)-positive HER2-negative breast cancer patients. In addition, the impact of MammaPrint on treatment in patients with T1a/T1b and pN0/pN1 (up to 1 node), Triple Negative or HER2-positive tumors will be assessed.

Breast Cancer

Agendia481 participantsStarted Nov 2015

Palm Springs, California, United States • Miami, Florida, United States • Tampa, Florida, United States +14 more locations

Letrozole in Treating Postmenopausal Women With Stage I, II or III Breast Cancer That Can Be Removed by Surgery

Measuring the Impact of MammaPrint on Adjuvant and Neoadjuvant Treatment in Breast Cancer Patients: A Prospective Registry

Breast Cancer Trials in Other Cities

Effect of Bisphosphonate on Bone Loss in Postmenopausal Women With Breast Cancer Initiating Aromatase Inhibitor Therapy

Patient Preference Survey for Radiation Oncologists

Digital Mammography Screening Trial (ACRIN6652)

A Study of SC-005 in Subjects With Triple Negative Breast Cancer (TNBC)

NOLAN: Naproxen or Loratadine and Neulasta

Brostallicin and Cisplatin in Treating Patients With Metastatic Breast Cancer

Quality of Life, Employment, and Informal Care Costs in Women Who Are Receiving Chemotherapy for Breast Cancer

A Study for Safety and Effectiveness of IMC-A12 by Itself or Combined With Antiestrogens to Treat Breast Cancer

Mastectomy Reconstruction Outcomes Consortium (MROC) Study

Clodronate With or Without Chemotherapy and/or Hormonal Therapy in Treating Women With Stage I or Stage II Breast Cancer

Prospective Observational Study Evaluating Treatment Decision Impact of Prosigna® in Early Stage Breast Cancer Patients

RAPID: Randomized Trial of Accelerated Partial Breast Irradiation

A Phase 1/2 Study Of HKI-272 (Neratinib) in Combination With Trastuzumab (Herceptin) In Subjects With Advanced Breast Cancer

Study Evaluating The Combination Of Neratinib And Capecitabine In Solid Tumors And Breast Cancer

Cryoablation of Small Breast Tumors in Early Stage Breast Cancer

A Study of a Combination of Trastuzumab and Capecitabine With or Without Pertuzumab in Patients With HER2-positive Metastatic Breast Cancer (PHEREXA)

Study Evaluating Neratinib (HKI-272) In Combination With Vinorelbine In Subjects With Solid Tumors And Metastatic Breast Cancer

A Multi-Center Study of Ibrutinib in Combination With MEDI4736 in Subjects With Relapsed or Refractory Solid Tumors

Other Conditions in Pittsburgh